Shares in Bruker, Stratagene Bounce Back | GenomeWeb

Shares in Bruker BioSciences and Stratagene continued their bumpy ride, bouncing back this week to post gains of 8.42 percent and 6.74 percent, respectively. Both firms' stocks had led decliners in the BCW Index last week, following a week of big gains.

Molecular Devices posted the largest decline for the week — 2.96 percent — giving back its gain of 2.69 percent during last week's tracking period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.